XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Statements of Income (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenue        
Revenue $ 10,717,824 $ 6,823,462 $ 18,054,231 $ 13,976,625
Cost of sales 2,402,781 1,544,134 4,054,628 3,313,715
Gross profit 8,315,043 5,279,328 13,999,603 10,662,910
Expenses        
Research and development 669,978 707,997 1,271,896 1,516,139
Selling, general, and administrative 435,625 483,116 806,946 949,734
Total expenses 1,105,603 1,191,113 2,078,842 2,465,873
Income from operations 7,209,440 4,088,215 11,920,761 8,197,037
Interest income 351,375 294,858 634,436 584,578
Income before taxes 7,560,815 4,383,073 12,555,197 8,781,615
Provision for income taxes 1,470,442 736,566 2,324,707 1,555,542
Net income $ 6,090,373 $ 3,646,507 $ 10,230,490 $ 7,226,073
Net income per share – basic (in dollars per share) $ 1.26 $ 0.75 $ 2.12 $ 1.50
Net income per share – diluted (in dollars per share) 1.26 0.75 2.12 1.49
Cash dividends declared per common share (in dollars per share) $ 1.00 $ 1.00 $ 2.00 $ 2.00
Weighted average shares outstanding        
Basic (in shares) 4,830,826 4,833,232 4,830,826 4,833,232
Diluted (in shares) 4,830,956 4,836,603 4,830,927 4,836,621
Product [Member]        
Revenue        
Revenue $ 10,514,539 $ 6,630,012 $ 17,587,500 $ 13,583,778
Contract Research and Development [Member]        
Revenue        
Revenue $ 203,285 $ 193,450 $ 466,731 $ 392,847